About Cybele Microbiome
Cybele Microbiome is a Healthcare company based in San Diego (United States) founded in 2017 by Nicole Scott and Eddie Adams. Prebiotics for skin care are provided through an AI-powered platform. Cybele Microbiome has raised $1.9 million across 5 funding rounds from investors including IndieBio and National Science Foundation. Its chief executive, as recorded, is Nicole Scott. Cybele Microbiome offers products and services including Rulo Skin Health and Microbiome Technology. Its focus areas include Life Sciences, Genomics, Genomics Research and Biomarker Discovery. Its legal entity is Cybele Microbiome, Inc. Its competitors include Avidity Biosciences, Metabolon and Sutro Biopharma; 3 of its 3 listed competitors have raised funding.
Company details
Cybele Microbiome was founded in 2017 in San Diego, United States, within the biotechnology sector. Next-generation genetic sequencing methods are utilized by the company to analyze microbiomes and develop prebiotic products aimed at skin health. New biomarkers are also created as part of its operations, with an emphasis on AI-driven platforms for product innovation and analysis.
- Headquarters San Diego, United States
- Founders Nicole Scott, Eddie Adams
- SectorsHealthcare
- Website cybelemicrobiome.com
- Social LinkedIn X
- Legal Name Cybele Microbiome, Inc.
- Total Equity Funding$1.9M (USD)
in 5 rounds
- Latest Funding Round$252K (USD), Seed
Feb 2024
- InvestorsIndieBio
& 1 more
Products & Services of Cybele Microbiome
Cybele Microbiome offers a comprehensive portfolio of products and services, including Rulo Skin Health and Microbiome Technology.
Platform for microbiome-based solutions to improve skin efficacy and reduce side effects
Technology analyzing ingredient effects on skin microbiome for health outcomes
Funding Insights of Cybele Microbiome
Cybele Microbiome has successfully raised a total of $1.9M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $252 thousand completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.9M
- Total Rounds 5
- Last Round Seed — $252,000
- First Round $893,500
(Oct 2018)
- Investors Count 2
All 5 funding rounds of Cybele Microbiome with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2024 | $252,000 | Seed | – | – | – |
| Nov 2022 | $500,000 | Seed | – | – | – |
| Jun 2020 | $250,000 | Seed | – | IndieBio | – |
| Feb 2019 | $225,000 | Grant | – | – | |
| Oct 2018 | $893,500 | Seed | – | – | – |
2 investors in total: 2 institutional.
Investors in Cybele Microbiome
Cybele Microbiome has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include IndieBio and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biotech startups are accelerated through IndieBio's focused programs. | indiebio.co | San Francisco, United States | ||
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States |
Investor details for Cybele Microbiome
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cybele Microbiome
4 people are tracked at Cybele Microbiome (3 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Nicole Scott | Co-Founder & CEO | Leadership |
Eddie Adams | Co-Founder & CSO | Leadership |
Brian Jessup | Co-Founder & Chief of Digital Growth & Customer Experience | Leadership |
Hui-Ling Seow | Marketing Strategist | Team |
Complete people profiles for Cybele Microbiome
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cybele Microbiome
3 dated milestones of Cybele Microbiome across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Cybele Microbiome is founded.
- Funding First funding round of $894K.
- Funding Latest funding round, Seed, of $252K.
Competitors of Cybele Microbiome
Cybele Microbiome has 3 listed competitors in our database, 3 of them funded. They include Avidity Biosciences, Metabolon and Sutro Biopharma.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| metabolon.com | 2000 | Morrisville, United States | $165.87M | 189 | Solutions for biomarker discovery and diagnostic testing are provided. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. |
Detailed competitors of Cybele Microbiome
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Cybele Microbiome (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cybele Microbiome
Cybele Microbiome was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Cybele Microbiome is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Nicole Scott is the CEO of Cybele Microbiome, as recorded in our data. They have also founded this company.
Cybele Microbiome is a funded company, having raised a total of $1.9M across 5 funding rounds to date. The company's 1st funding round was a Seed of $893.5K, raised on Oct 2018.
Cybele Microbiome was founded in 2017 in San Diego, United States, within the biotechnology sector. Next-generation genetic sequencing methods are utilized by the company to analyze microbiomes and develop prebiotic products aimed at skin health. New biomarkers are also created as part of its operations, with an emphasis on AI-driven platforms for product innovation and analysis.
Cybele Microbiome's top competitors include Sutro Biopharma, Avidity Biosciences and Metabolon.
Cybele Microbiome offers Rulo Skin Health and Microbiome Technology.
Cybele Microbiome has 2 investors. Key investors include IndieBio, and National Science Foundation.
Cybele Microbiome operates through Cybele Microbiome, Inc..